CVS Health Corp. closed 19.22% below its 52-week high of $80.75, which the company achieved on March 28th.

Walgreens Boots Alliance (WBA) has entered risky territory after the pharmacy chain announced a deal with Sycamore Partners.

CVS Health (CVS) is ditching retail sales to focus on pharmacy operations at 12 new locations opening in 2025. These new CVS ...

Research suggests that companies with above-average diversity in their management teams reported higher revenue increases ...

Shares of CVS Health Corp. CVS rallied 1.66% to $66.33 Friday, on what proved to be an all-around favorable trading session ...

The global Pharmacy Automation Market, valued at US$6.23 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching US$6.65 billion ...

The global Pharmacy Automation Market, valued at US$6.23 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, ...

While the overwhelming majority of Americans are not on Medicaid, it is important to recognize that sharp funding cuts to ...

(Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced a strategic ...

Walgreens and the private equity firm Sycamore Partners expect to close the take-private deal in the fourth quarter of this ...

Sycamore will pay $11.45 per share in cash for Walgreens. Shareholders could also receive up to $3 more per share in the ...

(Reuters) -Walgreens Boots Alliance will be taken private by Sycamore Partners for $10 billion, the buyout firm said on ...